Literature DB >> 30514492

Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Blanca I Restrepo1, Léanie Kleynhans2, Alejandra B Salinas3, Bassent Abdelbary4, Happy Tshivhula5, Genesis P Aguillón-Durán6, Carine Kunsevi-Kilola7, Gloria Salinas8, Kim Stanley9, Stephanus T Malherbe10, Elizna Maasdorp11, Moncerrato Garcia-Viveros12, Ilze Louw13, Esperanza M Garcia-Oropesa14, Juan Carlos Lopez-Alvarenga15, John B Prins16, Gerhard Walzl17, Larry S Schlesinger18, Katharina Ronacher19.   

Abstract

Type 2 diabetes (T2D) is a prevalent risk factor for tuberculosis (TB), but most studies on TB-T2D have focused on TB patients, been limited to one community, and shown a variable impact of T2D on TB risk or treatment outcomes. We conducted a cross-sectional assessment of sociodemographic and metabolic factors in adult TB contacts with T2D (versus no T2D), from the Texas-Mexico border to study Hispanics, and in Cape Town to study South African Coloured ethnicities. The prevalence of T2D was 30.2% in Texas-Mexico and 17.4% in South Africa, with new diagnosis in 34.4% and 43.9%, respectively. Contacts with T2D differed between ethnicities, with higher smoking, hormonal contraceptive use and cholesterol levels in South Africa, and higher obesity in Texas-Mexico (p < 0.05). PCA analysis revealed striking differences between ethnicities in the relationships between factors defining T2D and dyslipidemias. Our findings suggest that screening for new T2D in adult TB contacts is effective to identify new T2D patients at risk for TB. Furthermore, studies aimed at predicting individual TB risk in T2D patients, should take into account the heterogeneity in dyslipidemias that are likely to modify the estimates of TB risk or adverse treatment outcomes that are generally attributed to T2D alone.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Cholesterol; Diabetes; Ethnic; Metabolism; Tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 30514492      PMCID: PMC6284235          DOI: 10.1016/j.tube.2018.08.007

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  38 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Pitfalls in the use of HbA₁(c) as a diagnostic test: the ethnic conundrum.

Authors:  Samuel Dagogo-Jack
Journal:  Nat Rev Endocrinol       Date:  2010-08-03       Impact factor: 43.330

3.  The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study.

Authors:  Meghan A Baker; Hsien-Ho Lin; Hsing-Yi Chang; Megan B Murray
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

Review 4.  Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond.

Authors:  Gerald F Watts; Phillip Ya Ding; Peter George; Martin S Hagger; Miao Hu; Jie Lin; Kah Lin Khoo; A David Marais; Takashi Miida; Hapizah M Nawawi; Jing Pang; Jeong Euy Park; Lourdes B Gonzalez-Santos; Ta-Chen Su; Thanh Huong Truong; Raul D Santos; Handrean Soran; Shizuya Yamashita; Brian Tomlinson
Journal:  J Atheroscler Thromb       Date:  2016-07-06       Impact factor: 4.928

Review 5.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Authors:  Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

6.  Predictors of insulin sensitivity in Type 2 diabetes mellitus.

Authors:  E Bonora; G Targher; M Alberiche; G Formentini; F Calcaterra; S Lombardi; F Marini; M Poli; L Zenari; A Raffaelli; S Perbellini; M B Zenere; F Saggiani; R C Bonadonna; M Muggeo
Journal:  Diabet Med       Date:  2002-07       Impact factor: 4.359

7.  Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania.

Authors:  Daniel Faurholt-Jepsen; Nyagosya Range; George PrayGod; Kidola Jeremiah; Maria Faurholt-Jepsen; Martine G Aabye; John Changalucha; Dirk L Christensen; Harleen M S Grewal; Torben Martinussen; Henrik Krarup; Daniel R Witte; Aase B Andersen; Henrik Friis
Journal:  Trop Med Int Health       Date:  2013-05-06       Impact factor: 2.622

8.  Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: individual participant data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden countries.

Authors:  Jayadeep Patra; Prabhat Jha; Jürgen Rehm; Wilson Suraweera
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

9.  Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators.

Authors:  E Fair; C R Miller; S-E Ottmani; G J Fox; P C Hopewell
Journal:  Int J Tuberc Lung Dis       Date:  2015-03       Impact factor: 2.373

10.  Impact of diabetes and smoking on mortality in tuberculosis.

Authors:  George W Reed; Hongjo Choi; So Young Lee; Myungsun Lee; Youngran Kim; Hyemi Park; Jongseok Lee; Xin Zhan; Hyeungseok Kang; SooHee Hwang; Matthew Carroll; Ying Cai; Sang-Nae Cho; Clifton E Barry; Laura E Via; Hardy Kornfeld
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  8 in total

Review 1.  The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.

Authors:  Jose Cadena; Selvalakshmi Rathinavelu; Juan C Lopez-Alvarenga; Blanca I Restrepo
Journal:  Tuberculosis (Edinb)       Date:  2019-05-03       Impact factor: 3.131

2.  Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients.

Authors:  Blanca I Restrepo; Marcel Twahirwa; Chinnaswamy Jagannath
Journal:  Hum Immunol       Date:  2020-12-08       Impact factor: 2.211

3.  Human monocyte-derived macrophage responses to M. tuberculosis differ by the host's tuberculosis, diabetes or obesity status, and are enhanced by rapamycin.

Authors:  Blanca I Restrepo; Arshad Khan; Vipul K Singh; Génesis P Aguillón-Durán; Eder Ledezma-Campos; David H Canaday; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2020-12-30       Impact factor: 2.973

4.  Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.

Authors:  H A Rashak; H J Sánchez-Pérez; B E Abdelbary; A Bencomo-Alerm; N Enriquez-Ríos; A Gómez-Velasco; A Colorado; M Castellanos-Joya; M H Rahbar; B I Restrepo
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 5.  Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia.

Authors:  Minh Dao Ngo; Stacey Bartlett; Katharina Ronacher
Journal:  Microorganisms       Date:  2021-11-02

6.  Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective.

Authors:  Roma Sinha; Minh Dao Ngo; Stacey Bartlett; Helle Bielefeldt-Ohmann; Sahar Keshvari; Sumaira Z Hasnain; Meg L Donovan; Jessica C Kling; Antje Blumenthal; Chen Chen; Kirsty R Short; Katharina Ronacher
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 6.073

7.  A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.

Authors:  Julia M Scordo; Génesis P Aguillón-Durán; Doris Ayala; Ana Paulina Quirino-Cerrillo; Eminé Rodríguez-Reyna; Francisco Mora-Guzmán; Jose A Caso; Eder Ledezma-Campos; Larry S Schlesinger; Jordi B Torrelles; Joanne Turner; Blanca I Restrepo
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.752

8.  GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity.

Authors:  Stacey Bartlett; Adrian Tandhyka Gemiarto; Minh Dao Ngo; Haressh Sajiir; Semira Hailu; Roma Sinha; Cheng Xiang Foo; Léanie Kleynhans; Happy Tshivhula; Tariq Webber; Helle Bielefeldt-Ohmann; Nicholas P West; Andriette M Hiemstra; Candice E MacDonald; Liv von Voss Christensen; Larry S Schlesinger; Gerhard Walzl; Mette Marie Rosenkilde; Thomas Mandrup-Poulsen; Katharina Ronacher
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.